MedSource Named to Inc. 500/5000 List of Fastest-Growing Companies in America for the Second Time
Houston-based company ranks No. 1232 on the 2009 Inc. 5000 with three-year sales growth of 258 percent
Houston, TX, September 08, 2009 --(PR.com)-- Inc. magazine has ranked MedSource number 1232 on its third annual Inc. 5000, an exclusive ranking of the nation’s fastest-growing privately held companies. With a rapid growth rate of 258 percent over the past three years, the Houston-based Contract Research Organization (CRO) also earned a place in the top 100 health industry companies; coming in at No. 87. The Inc. 5000 is the most comprehensive look at the most important segment of the economy – America’s independent-minded entrepreneurs. Taken as a whole, these companies represent the backbone of the U.S. economy.
“Clinical research and drug development continue to be competitive markets in today’s global economy. We attribute our rapid growth and success to our talented team and look forward to continued success in this industry for years to come,” said Eric Lund, president of MedSource.
The companies that made this prestigious list reported aggregate revenue of $214 billion and a median three-year growth rate of 126 percent. Additionally, the Inc. 5000 are responsible for creating more than one million jobs since their founding. “Over the past year, we have expanded our team significantly; recently adding a Vice President of Clinical Operations, a Director of Regulatory Affairs, and other important team members necessary to manage MedSource’s growing business,” commented Lund.
MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. For more information, visit http://www.medsource.com. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria, can be found on Inc.com.
About Inc. 5000
The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008. To qualify, companies must have been founded and generating revenue by the first week of 2005, and therefore able to show four full calendar years of sales. Additionally, they have to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2008.
About MedSource
MedSource is a premier Contract Research Organization (CRO) dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. It has quickly grown into one of the premier CROs in North America and has been recognized as an Inc. 500/5000 company in 2008 and 2009, as well as a Houston Fast 100 company in 2009. Headquartered in Houston, TX, the company has offices in Raleigh, NC, clinical trial monitors located throughout North America, and active vendor relationships globally, allowing it to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at medsource.com or by calling (281) 286-2003.
###
“Clinical research and drug development continue to be competitive markets in today’s global economy. We attribute our rapid growth and success to our talented team and look forward to continued success in this industry for years to come,” said Eric Lund, president of MedSource.
The companies that made this prestigious list reported aggregate revenue of $214 billion and a median three-year growth rate of 126 percent. Additionally, the Inc. 5000 are responsible for creating more than one million jobs since their founding. “Over the past year, we have expanded our team significantly; recently adding a Vice President of Clinical Operations, a Director of Regulatory Affairs, and other important team members necessary to manage MedSource’s growing business,” commented Lund.
MedSource specializes in complex diseases and study designs and has experience in more than 400 trials in Phases I-IV. For more information, visit http://www.medsource.com. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria, can be found on Inc.com.
About Inc. 5000
The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008. To qualify, companies must have been founded and generating revenue by the first week of 2005, and therefore able to show four full calendar years of sales. Additionally, they have to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2008.
About MedSource
MedSource is a premier Contract Research Organization (CRO) dedicated to delivering on-time, reliable clinical trial management services. MedSource has been providing quality results in Phase I-IV studies since 2001 and has extensive experience in complex clinical trials, with a particular expertise on oncology related programs. It has quickly grown into one of the premier CROs in North America and has been recognized as an Inc. 500/5000 company in 2008 and 2009, as well as a Houston Fast 100 company in 2009. Headquartered in Houston, TX, the company has offices in Raleigh, NC, clinical trial monitors located throughout North America, and active vendor relationships globally, allowing it to quickly and effectively meet the clinical trial needs of their clients. More information about MedSource can be found at medsource.com or by calling (281) 286-2003.
###
Contact
MedSource
Chris Kohnhorst
281-203-7707
www.medsource.com
Chris Kohnhorst
281-203-7707
www.medsource.com
Contact
Categories